APO Research

APO RESEARCH · REPORT

Pregabalin Capsule

Selected research

Industry Growth & Trends

Global Pregabalin Capsule Industry Growth and Trends Forecast to 2032

Market perspective

The global Pregabalin Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pregabalin Capsule include Wan Vee Pharm, Succeway Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Stat Rx USA, Angita Pharma, Actavis Pharma and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pregabalin Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pregabalin Capsule market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pregabalin Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pregabalin Capsule.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pregabalin Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pregabalin Capsule Market by Company

Wan Vee Pharm

Succeway Pharmaceuticals

Qilu Pharmaceutical

Pfizer

Stat Rx USA

Angita Pharma

Actavis Pharma

Accord Healthcare

Pregabalin Capsule Segment by Type

75mg Capsule

50mg Capsule

25mg Capsule

Others

Pregabalin Capsule Segment by Application

Clinics

Hospitals

Others

Pregabalin Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pregabalin Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pregabalin Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 75mg Capsule Table 2. Major Company of 50mg Capsule Table 3. Major Company of 25mg Capsule Table 4. Major Company of Others Table 5. Global Pregabalin Capsule Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 7. Global Pregabalin Capsule Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pregabalin Capsule Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pregabalin Capsule Sales Market Share in Value by Type (2021-2026) Table 10. Global Pregabalin Capsule Price by Type (2021-2026) & (US$/unit) Table 11. Global Pregabalin Capsule Sales by Type (2027-2032) & (k units) Table 12. Global Pregabalin Capsule Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pregabalin Capsule Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pregabalin Capsule Sales Market Share in Value by Type (2027-2032) Table 15. Global Pregabalin Capsule Price by Type (2027-2032) & (US$/unit) Table 16. North America Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 17. North America Pregabalin Capsule Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 19. Europe Pregabalin Capsule Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Pregabalin Capsule Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 23. Latin America Pregabalin Capsule Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Pregabalin Capsule Sales by Type (2021-2026) & (US$ Million) Table 26. Pregabalin Capsule Industry Trends Table 27. Pregabalin Capsule Industry Drivers Table 28. Pregabalin Capsule Industry Opportunities and Challenges Table 29. Pregabalin Capsule Industry Restraints Table 30. Global Pregabalin Capsule Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pregabalin Capsule Revenue Market Share by Company (2021-2026) Table 32. Global Pregabalin Capsule Sales by Company (2021-2026) & (k units) Table 33. Global Pregabalin Capsule Sales Share by Company (2021-2026) Table 34. Global Pregabalin Capsule Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Pregabalin Capsule Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pregabalin Capsule Major Company Production Sites and Headquarters Table 37. Global Pregabalin Capsule Company, Product Type & Application Table 38. Global Pregabalin Capsule Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pregabalin Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pregabalin Capsule Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pregabalin Capsule Sales by Region (2021-2026) & (k units) Table 43. Global Pregabalin Capsule Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pregabalin Capsule Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pregabalin Capsule Sales Market Share in Value by Region (2021-2026) Table 46. Global Pregabalin Capsule Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Pregabalin Capsule Sales by Region (2027-2032) & (k units) Table 48. Global Pregabalin Capsule Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pregabalin Capsule Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pregabalin Capsule Sales Market Share in Value by Region (2027-2032) Table 51. Global Pregabalin Capsule Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Pregabalin Capsule Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 54. Global Pregabalin Capsule Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pregabalin Capsule Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pregabalin Capsule Sales Market Share in Value by Application (2021-2026) Table 57. Global Pregabalin Capsule Price by Application (2021-2026) & (US$/unit) Table 58. Global Pregabalin Capsule Sales by Application (2027-2032) & (k units) Table 59. Global Pregabalin Capsule Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pregabalin Capsule Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pregabalin Capsule Sales Market Share in Value by Application (2027-2032) Table 62. Global Pregabalin Capsule Price by Application (2027-2032) & (US$/unit) Table 63. North America Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 64. North America Pregabalin Capsule Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 66. Europe Pregabalin Capsule Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Pregabalin Capsule Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 70. Latin America Pregabalin Capsule Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Pregabalin Capsule Sales by Application (2021-2026) & (US$ Million) Table 73. Wan Vee Pharm Company Information Table 74. Wan Vee Pharm Business Overview Table 75. Wan Vee Pharm Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Wan Vee Pharm Pregabalin Capsule Product Portfolio Table 77. Wan Vee Pharm Recent Development Table 78. Succeway Pharmaceuticals Company Information Table 79. Succeway Pharmaceuticals Business Overview Table 80. Succeway Pharmaceuticals Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio Table 82. Succeway Pharmaceuticals Recent Development Table 83. Qilu Pharmaceutical Company Information Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Qilu Pharmaceutical Pregabalin Capsule Product Portfolio Table 87. Qilu Pharmaceutical Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Pfizer Pregabalin Capsule Product Portfolio Table 92. Pfizer Recent Development Table 93. Stat Rx USA Company Information Table 94. Stat Rx USA Business Overview Table 95. Stat Rx USA Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Stat Rx USA Pregabalin Capsule Product Portfolio Table 97. Stat Rx USA Recent Development Table 98. Angita Pharma Company Information Table 99. Angita Pharma Business Overview Table 100. Angita Pharma Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Angita Pharma Pregabalin Capsule Product Portfolio Table 102. Angita Pharma Recent Development Table 103. Actavis Pharma Company Information Table 104. Actavis Pharma Business Overview Table 105. Actavis Pharma Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Actavis Pharma Pregabalin Capsule Product Portfolio Table 107. Actavis Pharma Recent Development Table 108. Accord Healthcare Company Information Table 109. Accord Healthcare Business Overview Table 110. Accord Healthcare Pregabalin Capsule Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Accord Healthcare Pregabalin Capsule Product Portfolio Table 112. Accord Healthcare Recent Development Table 113. North America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. North America Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 115. North America Pregabalin Capsule Sales Market Share by Country (2021-2026) Table 116. North America Pregabalin Capsule Sales Forecast by Country (2027-2032) & (k units) Table 117. North America Pregabalin Capsule Sales Market Share Forecast by Country (2027-2032) Table 118. North America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Pregabalin Capsule Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Pregabalin Capsule Market Share by Country (2021-2026) Table 121. North America Pregabalin Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Pregabalin Capsule Market Share Forecast by Country (2027-2032) Table 123. Europe Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Europe Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 125. Europe Pregabalin Capsule Sales Market Share by Country (2021-2026) Table 126. Europe Pregabalin Capsule Sales Forecast by Country (2027-2032) & (k units) Table 127. Europe Pregabalin Capsule Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Pregabalin Capsule Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Pregabalin Capsule Market Share by Country (2021-2026) Table 131. Europe Pregabalin Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Pregabalin Capsule Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 135. Asia-Pacific Pregabalin Capsule Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Pregabalin Capsule Sales Forecast by Country (2027-2032) & (k units) Table 137. Asia-Pacific Pregabalin Capsule Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Pregabalin Capsule Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Pregabalin Capsule Market Share by Country (2021-2026) Table 141. Asia-Pacific Pregabalin Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Pregabalin Capsule Market Share Forecast by Country (2027-2032) Table 143. Latin America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Latin America Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 145. Latin America Pregabalin Capsule Sales Market Share by Country (2021-2026) Table 146. Latin America Pregabalin Capsule Sales Forecast by Country (2027-2032) & (k units) Table 147. Latin America Pregabalin Capsule Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Pregabalin Capsule Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Pregabalin Capsule Market Share by Country (2021-2026) Table 151. Latin America Pregabalin Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Pregabalin Capsule Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 155. Middle East and Africa Pregabalin Capsule Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Pregabalin Capsule Sales Forecast by Country (2027-2032) & (k units) Table 157. Middle East and Africa Pregabalin Capsule Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Pregabalin Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Pregabalin Capsule Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Pregabalin Capsule Market Share by Country (2021-2026) Table 161. Middle East and Africa Pregabalin Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Pregabalin Capsule Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Pregabalin Capsule Distributors List Table 166. Pregabalin Capsule Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Pregabalin Capsule Image Figure 2. Global Pregabalin Capsule Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregabalin Capsule Market Size (2021-2032) & (US$ Million) Figure 4. Global Pregabalin Capsule Sales (2021-2032) & (k units) Figure 5. 75mg Capsule Image Figure 6. Global 75mg Capsule Sales YoY Growth (2021-2032) & (k units) Figure 7. 50mg Capsule Image Figure 8. Global 50mg Capsule Sales YoY Growth (2021-2032) & (k units) Figure 9. 25mg Capsule Image Figure 10. Global 25mg Capsule Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Pregabalin Capsule Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pregabalin Capsule Market Share by Type 2025 VS 2032 Figure 15. North America Pregabalin Capsule Sales Market Share in Volume by Type in 2025 Figure 16. North America Pregabalin Capsule Sales Market Share in Value by Type in 2025 Figure 17. Europe Pregabalin Capsule Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pregabalin Capsule Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pregabalin Capsule Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pregabalin Capsule Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pregabalin Capsule Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pregabalin Capsule Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pregabalin Capsule Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pregabalin Capsule Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pregabalin Capsule Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Pregabalin Capsule Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pregabalin Capsule Market Share by Application 2025 VS 2032 Figure 35. North America Pregabalin Capsule Sales Market Share in Volume by Application in 2025 Figure 36. North America Pregabalin Capsule Sales Market Share in Value by Application in 2025 Figure 37. Europe Pregabalin Capsule Sales Market Share in Volume by Application in 2025 Figure 38. Europe Pregabalin Capsule Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Pregabalin Capsule Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Pregabalin Capsule Sales Market Share in Value by Application in 2025 Figure 41. Latin America Pregabalin Capsule Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Pregabalin Capsule Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Pregabalin Capsule Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Pregabalin Capsule Sales Market Share in Value by Application in 2025 Figure 45. North America Pregabalin Capsule Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Pregabalin Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Pregabalin Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pregabalin Capsule Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Pregabalin Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Pregabalin Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pregabalin Capsule Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Pregabalin Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Pregabalin Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pregabalin Capsule Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Pregabalin Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Pregabalin Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pregabalin Capsule Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Pregabalin Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Pregabalin Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pregabalin Capsule Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Pregabalin Capsule Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 75mg Capsule
  • 50mg Capsule
  • 25mg Capsule
  • Others
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Wan Vee Pharm
  • Succeway Pharmaceuticals
  • Qilu Pharmaceutical
  • Pfizer
  • Stat Rx USA
  • Angita Pharma
  • Actavis Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pregabalin Capsule Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pregabalin Capsule Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pregabalin Capsule Market by Type
  6. 1.3.1 75mg Capsule
  7. 1.3.2 50mg Capsule
  8. 1.3.3 25mg Capsule
  9. 1.3.4 Others
  10. 1.4 Global Pregabalin Capsule Market Size by Type
  11. 1.4.1 Global Pregabalin Capsule Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pregabalin Capsule Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pregabalin Capsule Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pregabalin Capsule Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pregabalin Capsule Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pregabalin Capsule Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pregabalin Capsule Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pregabalin Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pregabalin Capsule Industry Trends
  2. 2.2 Pregabalin Capsule Industry Drivers
  3. 2.3 Pregabalin Capsule Industry Opportunities and Challenges
  4. 2.4 Pregabalin Capsule Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pregabalin Capsule Revenue (2021-2026)
  2. 3.2 Global Top Players by Pregabalin Capsule Sales (2021-2026)
  3. 3.3 Global Top Players by Pregabalin Capsule Price (2021-2026)
  4. 3.4 Global Pregabalin Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pregabalin Capsule Major Company Production Sites & Headquarters
  6. 3.6 Global Pregabalin Capsule Company, Product Type & Application
  7. 3.7 Global Pregabalin Capsule Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pregabalin Capsule Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pregabalin Capsule Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pregabalin Capsule Tier 1, Tier 2, and Tier 3
4 Pregabalin Capsule Regional Status and Outlook
  1. 4.1 Global Pregabalin Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pregabalin Capsule Historic Market Size by Region
  3. 4.2.1 Global Pregabalin Capsule Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pregabalin Capsule Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pregabalin Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pregabalin Capsule Forecasted Market Size by Region
  7. 4.3.1 Global Pregabalin Capsule Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pregabalin Capsule Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pregabalin Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pregabalin Capsule by Application
  1. 5.1 Pregabalin Capsule Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Pregabalin Capsule Market Size by Application
  6. 5.2.1 Global Pregabalin Capsule Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pregabalin Capsule Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pregabalin Capsule Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pregabalin Capsule Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pregabalin Capsule Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pregabalin Capsule Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pregabalin Capsule Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pregabalin Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wan Vee Pharm
  2. 6.1.1 Wan Vee Pharm Company Information
  3. 6.1.2 Wan Vee Pharm Business Overview
  4. 6.1.3 Wan Vee Pharm Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wan Vee Pharm Pregabalin Capsule Product Portfolio
  6. 6.1.5 Wan Vee Pharm Recent Developments
  7. 6.2 Succeway Pharmaceuticals
  8. 6.2.1 Succeway Pharmaceuticals Company Information
  9. 6.2.2 Succeway Pharmaceuticals Business Overview
  10. 6.2.3 Succeway Pharmaceuticals Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio
  12. 6.2.5 Succeway Pharmaceuticals Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Pregabalin Capsule Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Pregabalin Capsule Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Stat Rx USA
  26. 6.5.1 Stat Rx USA Company Information
  27. 6.5.2 Stat Rx USA Business Overview
  28. 6.5.3 Stat Rx USA Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stat Rx USA Pregabalin Capsule Product Portfolio
  30. 6.5.5 Stat Rx USA Recent Developments
  31. 6.6 Angita Pharma
  32. 6.6.1 Angita Pharma Company Information
  33. 6.6.2 Angita Pharma Business Overview
  34. 6.6.3 Angita Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Angita Pharma Pregabalin Capsule Product Portfolio
  36. 6.6.5 Angita Pharma Recent Developments
  37. 6.7 Actavis Pharma
  38. 6.7.1 Actavis Pharma Company Information
  39. 6.7.2 Actavis Pharma Business Overview
  40. 6.7.3 Actavis Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Actavis Pharma Pregabalin Capsule Product Portfolio
  42. 6.7.5 Actavis Pharma Recent Developments
  43. 6.8 Accord Healthcare
  44. 6.8.1 Accord Healthcare Company Information
  45. 6.8.2 Accord Healthcare Business Overview
  46. 6.8.3 Accord Healthcare Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Accord Healthcare Pregabalin Capsule Product Portfolio
  48. 6.8.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Pregabalin Capsule Sales by Country
  2. 7.1.1 North America Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pregabalin Capsule Sales by Country (2021-2026)
  4. 7.1.3 North America Pregabalin Capsule Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pregabalin Capsule Market Size by Country
  6. 7.2.1 North America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pregabalin Capsule Market Size by Country (2021-2026)
  8. 7.2.3 North America Pregabalin Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pregabalin Capsule Sales by Country
  2. 8.1.1 Europe Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pregabalin Capsule Sales by Country (2021-2026)
  4. 8.1.3 Europe Pregabalin Capsule Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pregabalin Capsule Market Size by Country
  6. 8.2.1 Europe Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pregabalin Capsule Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pregabalin Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pregabalin Capsule Sales by Country
  2. 9.1.1 Asia-Pacific Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pregabalin Capsule Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pregabalin Capsule Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pregabalin Capsule Market Size by Country
  6. 9.2.1 Asia-Pacific Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pregabalin Capsule Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pregabalin Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pregabalin Capsule Sales by Country
  2. 10.1.1 South America Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pregabalin Capsule Sales by Country (2021-2026)
  4. 10.1.3 South America Pregabalin Capsule Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pregabalin Capsule Market Size by Country
  6. 10.2.1 South America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pregabalin Capsule Market Size by Country (2021-2026)
  8. 10.2.3 South America Pregabalin Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pregabalin Capsule Sales by Country
  2. 11.1.1 Middle East and Africa Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pregabalin Capsule Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pregabalin Capsule Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pregabalin Capsule Market Size by Country
  6. 11.2.1 Middle East and Africa Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pregabalin Capsule Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pregabalin Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pregabalin Capsule Value Chain Analysis
  2. 12.1.1 Pregabalin Capsule Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pregabalin Capsule Production Mode & Process
  7. 12.2 Pregabalin Capsule Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pregabalin Capsule Distributors
  10. 12.2.3 Pregabalin Capsule Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research